Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational - Characterizing the Frequency and Spectrum of ALK Mutations in Neuroblastoma

NCT00907920 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00907920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00907920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational - Characterizing the Frequency and Spectrum of ALK Mutations in Neuroblastoma
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
December 31, 2008
Completion date
December 31, 2008
Enrollment
1,500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma